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Abstract. The Pringle maneuver is used in hepatic surgery to prevent blood loss but is associated with isch-
emia-reperfusion injury. To investigate the effect of infliximab on inflammation and apoptosis in rat intestinal 
mucosa during ischemia-reperfusion (IR) injury. A total of 30 male Wistar albino rats were equally divided into 
three groups to be subjected to (i) sham operation (sham), (ii) IR injury via Pringle maneuver (pringle) or (iii) 
infliximab (IFX) group (IFX was given at a dose 3 mg/kg for 3 days before IR injury). Following reperfusion 
period of 60 min., intestinal tissue and blood samples were taken and processed by standard histological methods. 
The Pringle maneuver and following reperfusion caused significant histopathological changes, increased serum 
transaminases’ activity and the levels of oxidative stress markers and decreased glutathione peroxidase activity. 
IFX pretreatment partially prevented these changes. Infliximab pretreatment may protect intestinal mucosa 
against ischemia-reperfusion injury. Further studies are needed to investigate mechanism and evaluate safety 
and optimal dosing of IFX in humans exposed to the possible tissue damage by ischemia-reperfusion. (Folia 
Histochemica et Cytobiologica 2014, Vol. 52, No. 1, 36–41)
Key words: Pringle maneuver; ischemia-reperfusion injury; TNF; infliximab; calcineurin; caspase 3;  
transaminases; oxidative stress 
Corresponding author: B. Erdivanlı M.D., Recep Tayyip 
Erdoğan Üniversitesi Eğitim ve Araştırma Hastanesi, İslampaşa 
Mahallesi, Şehitler caddesi, No: 74, 53100, Rize 
tel.: +90 464 213 04 91; fax: +90 464 217 03 64; 
e-mail: berdivanli@gmail.com
Introduction
Surgery and general anesthesia during hepatic surge-
ry may cause tissue hypoxia due to decreased tissue 
perfusion. Ischemic period is particularly long in 
tumor, trauma or transplantation cases, where Pringle 
maneuver is commonly used. Ischemia-reperfusion 
injury (IRI) results in immunological [1], metabolic 
[2] and microvascular changes [3], cellular damage 
and dysfunction [4]. IRI may also occur in extrahe-
patic tissues [5], such as lung [6], kidney [7] and small 
intestine, depending on systemic response.
Extent of injury increases during reperfusion when 
oxygen reaches ischemic tissues. Oxygen radicals, 
inflammatory cytokines and neutrophiles’ activation 
play a key role in the development of IRI [8]. Inter-
leukin-2 (IL-2) and tumor necrosis factor-a (TNF-a) 
are the most potent triggers of this cascade. Both 
IL-2 and TNF-a are produced in T-cells in a pro - 
cesses which involve action of calcineurin (Cn) and 
caspase enzymes, respectively [9]. Infliximab (IFX), 
used in the treatment of inflammatory bowel disease 
and rheumatic disease [10], inhibits TNF-a activity 
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as chimeric monoclonal IgG antibody [11, 12] and 
decreases free oxygen radical formation [13]. We 
hypothesized that infliximab may prevent IRI in in-
testine wall. Following IRI, the number of apoptotic 
cells in small intestine’s wall increases with mucosal 
erosion, edema, and villous denudation [14]. Calci-
neurin is a serine phosphatase, which dephosphory-
lates nuclear factor of activated T-cells (upon contact 
with increased intracellular calcium) and mediates 
further T-cell activation and IL-2 production [14]. Cn 
expression was demonstrated in several tissues in rat 
[15–17]. The caspase 3 (Casp3) protein is a member 
of the cysteine-aspartic acid protease (caspase) fa-
mily. Casp3 is a zymogen, which can be activated via 
binding of TNF-a to TNFR1, and causes apoptosis 
in cells targeted by cytotoxic T-cells. Therefore, we 
investigated Casp3 and Cn expression by immunohi-
stochemistry under the conditions of IFX’s effect on 
the outcome of ischemia-reperfusion resulting from 
Pringle maneuver.
Material and methods
A total of 30 adult male Wistar albino rats weighing 
275–300 g were housed in a sterile environment at 
a room temperature of 22 ± 3oC and 55–60% humidity 
with 12 hour lighting. Animals were fed with pelle-
ted rat food and water ad libitum. Methods used for 
animal experiments were regulated according to the 
protocol of National Institute of Health Guide for the 
Care and Use of Laboratory Animals. Necessary per-
missions were received from Recep Tayyip Erdogan 
University Faculty of Medicine Animal Experiments 
Local Ethics Committee (Date: 31.01.2012, Decision 
no: 02).
The primary outcome was to document changes in 
rat intestinal cell morphology using histopathological, 
light microscopic and immunohistochemical methods. 
Secondary endpoint was to document changes in 
serum TNF-a, malondialdehyde (MDA), glutathio-
ne-peroxidase (GSH-Px), alanine aminotransferase 
(ALT) and aspartate aminotransferase (AST) levels. 
Rats were randomized into three groups (n = 10 each) 
as (i) sham operation, i.e. control group (sham), (ii) 
ischemia-reperfusion injury caused by Pringle ma-
neuver (Pringle group), and (iii) infliximab+pringle 
group (rats received 3 mg/kg intraperitoneally IFX 
for 3 days before ischemia-reperfusion).
Pelleted food intake was restricted 12 hours and 
water intake 2 hours before anesthesia. Anesthesia 
was achieved via i.p. injection of 50 mg/kg i.p. ke-
tamine (Ketalar®, Parke-Davis, Istanbul, Turkey) 
and 5 mg/kg xylazine (Rompun®, Bayer, Istanbul, 
Turkey). Following midline incision in the abdomen, 
the hepatic hilus was explored and the hepatic pedicle 
was clamped. After 90 min, the clamp was opened 
to reperfuse the liver for 60 min. Thereafter, ileum 
and 6 ml blood from right ventricle were taken. The 
animals were killed by exsanguination through cardiac 
puncture and blood collection.
Histopathology. The small intestine specimens were fixed 
in 10% neutral formaldehyde for 24 hours, washed under 
running water for 8 hours and embedded into liquid paraffin 
by rinsing out with ethanol-xylene series, using automated 
tissue follow-up system (Citadel 2000, Thermo Fisher 
Scientific, Shandon, England). Tissues were cut in 5 μm 
thickness using rotary microtome (RM2255, Leica, Wetzlar, 
Germany) for hematoxylin and eosin (H&E) staining and 
in 3 μm thickness for immunohistochemical staining. Tissue 
sections stained with H&E were examined with a digital 
camera (DP72, Olympus, Tokyo, Japan) attached to light 
microscope (BX51, Olympus, Tokyo, Japan).
Immunohistochemistry. Calcineurin and Caspase 
3 expression was analyzed by immunohistochemistry using 
a streptavidin-biotin peroxidase method. EnVisionTM FLEX 
DAB chromogen (DM827, DAKO, Glostrup, Denmark) and 
EnVision TM FLEX Substrate Buffer (DM823, DAKO) to 
detect peroxidase activity. Small intestinal tissue specimens 
were deparaffinized with xylene for streptavidin-biotin 
peroxidase method and rehydrated in graded ethanol se-
ries. Slices were incubated in 3% H2O2 to block endogen 
peroxidase activity and in normal bovine serum to block 
nonspecific binding sites of antibodies. Sections were incu-
bated with primary antibody to calcineurin (Purified Mouse 
Anti-Calcineurin, clone 29-Calcineurin, 1:200 dilution, 
BD Biosciences, San Diego, California, USA) and CASP3 
(Anti-active Caspase-3 antibody, ab13847, 1:50, Abcam, 
Cambridge, MA, USA) for 60 min at room temperature 
(23oC), and then incubated in a biotinylated secondary anti-
body (Streptavidin-Horseradish Peroxidase Universal LSAB 
Kit-K0690, DAKO) for 30 min. Antibody binding sites were 
stained with 3,3-diaminobenzidine (DAB), and washed with 
phosphate-buffered saline (PBS). Nuclei were stained with 
EnVisionTM FLEX Hematoxylin (Code K8018, DAKO), 
dehydrated in ethanol series and cleared with xylene. The 
treated sections were then mounted with Entellan medium 
(Code 107960, Merck, Darmstadt, Germany) and examined 
under light microscope. Tissue injury in the intestinal muco-
sa was evaluated using light microscope according to criteria 
described by Chiu et al. and scored between 0 and 5 [18].
Biochemical assays. TNF-a concentration in serum speci-
mens was measured using an enzyme amplified sensitivity 
immunoassay method according to manufacturer’s protocol 
(DIAsource ImmunoAssays, Louvain-la-Neuve, Belgium) 
and measured on microplate reader (Sunrise-Basic, Tecan, 
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Grödig, Austria). Results were expressed as pg/mL. MDA 
level in serum specimens was measured with the method of 
Draper et al [19]. After trichloroacetic acid was pipetted into 
serum specimens, they were incubated at 90°C for 15 min 
and centrifuged at 4°C at 3000 g for 20 min. Thiobarbituric 
acid was added into supernatant obtained, and absorbance 
of specimens was determined at 532 nm. MDA amount was 
calculated on the basis of molar extinction coefficient (1,56 
× 105M-1 × cm-1) of TBA-MDA complex. Results of lipid pe-
roxidation were expressed as μmol/dL. GSH-Px activity was 
measured according to the method of Paglia et al [20]. GSH
-Px catalyzes oxidation of reduced glutathione to oxidized 
glutathione. At the next stage, formed glutathione is reduced 
to reduced glutathione in the presence of glutathione reduc-
tase and NADPH. For that purpose, serum was pipetted 
into the medium containing reduced glutathione, NADPH, 
glutathione reductase and incubated at room temperature 
for 30 min. At the next stage, hydrogen peroxide was added, 
and decrease in absorbance was recorded. GSH-Px level 
was calculated and expressed as U/dL [21]. Serum ALT 
and AST activities were measured via spectrophotometric 
method using an autoanalyzer (P800 Modular Analytics P, 
Roche Diagnostic Ltd., West Sussex, UK).
Statistical analysis. Data were analyzed using the SPSS pro-
gram (SPSS for Windows, v. 12.0, IBM, Chicago, IL, USA). 
AST, ALT, MDA, TNF, and GSH-Px values were expressed 
as mean ± SD, analyzed using one-way ANOVA analysis of 
variance with least significant difference (p < 0.05). Multiple 
comparison tests (Post-Hoc Tukey HSD parametric tests) 
were used to identify significant differences between groups. 
For comparisons between groups, p value was divided into 
the number of comparisons, which gives a p value of 0.05/3 
= 0.017. Histopathological grades, degree of inflammatory 
cell infiltration, intensity grades of Casp3 and Cn stainings 
were expressed as median (min-max). Kruskal-Wallis test 
was used for inter-group analysis (p < 0.05) and Mann-Whit-
ney-U test for pairwise comparison of groups).
Results
Histopathologic evaluation
Small intestine specimens of sham group showed 
normal intestinal mucosa and villi with tall columnar 
epithelium and numerous goblet cells within nor-
mal histomorphological structure (Figure 1A). The 
morpholgy of the intestinal mucosa in the ischemia
-reperfusion (Pringle) group is shown in Figure 1B. 
We observed significant epithelial cell loss (cellular 
debris inside the lumen) compared with sham group. 
Moreover, we found decreased capillary density and 
presence of erythrocytes in broad and shortened villi 
with necrotic tips, vacuolization in muscular layer, 
dilation in majority of capillary vessels both in the mu-
cosal and muscular layers, significant mucosal edema, 
many leukocytes and swollen endothelial cells in the 
postcapillary venules of the small intestine (Figure 
1B). Infliximab+pringle group (Figure 1C) showed 
slight edema, epithelial cell degeneration and necro-
sis in mucosal villi. We observed slight vacuolization 
in lamina propria and villi with few goblet cells and 
columnar epithelium. Moreover, there was a slight 
increase in the number of erythrocytes, leukocytes 
and endothelial cells in the postcapillary venules of 
the bowel (Figure 1C).
Lymphocytic infiltration was absent in sham group, 
however, it was severe in Pringle group (especially 
in mucosal epithelial layer) and moderate in inflixi-
mab+pringle group (in mucosal epithelial layer, 
inside the lamina propria and around the vessels) 
(Figure 1).
Immunohistochemical demonstration  
of calcineurin and caspase 3
Sham group showed high Cn immunopositivity in in-
testinal villi, near crypts and in regions close to tunica 
Figure 1. Histopathological changes observed in rat small 
intestine specimens (H&E staining). A. Sham group, × 40, 
bar 20 μm. B. Pringle group, × 20, bar 50 μm. C. Infliximab 
+ pringle group, × 40, bar 20 μm. Abbreviations and sym-
bols: e: edema; ed: epithelial degeneration; i: lymphocyte 
infiltration; L: lumen; arrowhead: normal epithelium
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muscularis layer (Table 1, Figure 2A). Pringle group 
showed weak Cn immunopositivity near intestinal 
crypts and in unexfoliated regions of epithelium. Exfo-
liated and edematous regions showed no or weak Cn 
immunopositivity (Figure 2B). Infliximab + pringle 
group (Figure 2C) showed moderate Cn immuno-
positivity in the apical region of epithelial cells and 
close to intestinal crypts. The staining was weak in the 
region between crypts and tunica muscularis and was 
absent in edematous regions (Table 1, Figure 2C).
All groups showed weak caspase 3 immunore-
activity in the epithelium of intestinal villi and to a 
lesser extent in tunica muscularis and crypts. (Table 1, 
Figure 3). The staining was slightly more pronounced 
in Pringle group in epithelial cells and was especially 
strong in exfoliated cells (Table 1, Figure 3B). The 
difference in the staining intensity between sham 
and infliximab+pringle groups was non-significant, 
while statistically significant differences were found 
between Pringle and other groups (p = 0.006).
Table 1. Inflammatory and immunoreactivity scoring (on a scale of 0 to 5) of small intestine mucosa.
Sham (n = 10) Pringle (n = 10) Pringle + infliximab (n = 10)
Inflammatory cell infiltration 0 (0–4)* 3 (1–3) 2 (1–2)†
Calcineurin expression 3 (2–3)* 1 (1–2) 2 (1–3)†
Caspase-3 expression 1.5 (1–2) 2 (2–3)* 1.5 (1–2)
Calcineurin and caspase-3 expression was visualized by immunohistochemistry. Data are presented as median and range (min-max); *p < 0.015 vs. 
other groups; †p < 0.015 vs. pringle group
Figure 2. Calcineurin expression in the mucosa of rat small intesti-
ne. A. Sham group, × 40, bar 20 μm. B. Pringle group, e: edema, i: 
lymphocyte infiltration; × 40, bar, 20 μm. C. Infliximab+pringle 
group,; × 40, bar: 20 μm. Calcineurine expression was visu-
alized by immunohistochemistry as described in Methods.  
Abbreviations as for Figure 1. Symbols: arrowhead, high immu-
nopositive reaction (+++); circle: moderate positivity (++)
Figure 3. Caspase-3 expression in epithelial cells of the 
small intestine. A. Sham group, × 20, bar 50 μm. B. Pringle 
group, × 40, bar 20 μm. C. Infliximab+pringle group, × 
40, bar: 20 μm. 
Abbreviations as for Figure 1. Symbols: arrowhead: mode-
rate immunoreactivity (++); circle, weak immunoreacti-
vity (+)
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Serum ALT and AST activities significantly increased 
in Pringle and infliximab+pringle groups compared 
with sham group (Table 2). Serum TNF-a and MDA 
levels were significantly higher in Pringle group com-
pared with sham group. Serum GSH-Px activity was 
significantly reduced in Pringle group compared with 
sham group (p < 0.05), and did not differ between 
the infliximab+pringle group and with sham group 
(Table 2).
Discussion
This study showed that infliximab pretreatment may 
inhibit Pringle maneuver-induced injury in epithelial 
cells of small intestine. We evaluated IR-induced 
epithelial injury by using scoring system described by 
Chiu et al. [18], which is commonly used for histo-
pathological grading of intestinal ischemia, and our 
findings are comparable to current literature [22].
The main histopathological findings in Pringle 
group were severe degeneration and Casp3 reactivity 
in the intestinal epithelial cells. These findings are 
similar to previous reports on ischemic injury follo-
wing blockade of superior mesenterial artery [20, 23, 
24]. As expected, Pringle group showed substantially 
higher serum TNF-a level. This is consistent with high 
Casp3 activity and therefore apoptosis was pronoun-
ced in this group. Interestingly, TNF-a serum con-
centration did not differ between infliximab+pringle 
group compared with sham group which may explain 
why intensity of Casp3 staining was similar in sham 
and infliximab + pringle groups. We still observed 
mild epithelial injury in infliximab + pringle group, 
however, we also observed cellular regeneration 
in this group. This suggests that although ischemic 
period causes cellular degeneration and apoptosis, 
TNF-a blockage with infliximab prevents further 
inflammation and degeneration. GSH-Px plays an 
important role in oxidant/antioxidant balance in the 
intestines [25, 26]. As GSH-Px levels were similar 
in sham and infliximab + pringle groups, in case of 
TNF-a blockage with infliximab, remaining epithelial 
cells may regenerate.
It is interesting that intensity of Cn staining was 
highest in sham group and lowest in Pringle group. It 
has been demonstrated that Cn induced production 
of IL-2 which inhibited CD4+CD25 regulatory T 
cell function [27]. On the other hand, IL-2 is known 
to induce TNF-a gene expression [28]. As we did not 
measured the serum or cytosolic calcium levels, and 
also did not subtyped Cn (as CnA and CnB), which are 
major limitations of our study, we cannot determine 
whether Cn was associated with proinflammatory or 
mitotic activity. We hypothesize that since T-cell nuc-
lear factor dephosphorylation and re-phosphorylation 
occurs as quickly as 15 minutes [29], our reperfusion 
period of 60 minutes may have been too long to detect 
a possible change in Cn expression.
MDA is a marker of lipid peroxidation in ischemic 
tissues [30]. Intensity of MDA staining was the same 
in sham and infliximab + pringle groups and high in 
Pringle group. This suggests that administration of 
infliximab before ischemic period prevented lipid de-
gradation by reactive oxygen species. Serum AST level 
increased 7-fold in Pringle group but only doubled in 
infliximab+pringle group. Since AST is a marker of 
small intestine epithelial cell damage, this data may 
reflect the inhibitory effect of infliximab on inflamma-
tory epithelial cell injury. Serum ALT level increased 
60-fold in Pringle group but only 7-fold in infliximab 
+ pringle group. Since ALT is a marker of liver cell 
injury, this suggests that infliximab pretreatment 
alleviated ischemia-reperfusion injury in the liver.
We conclude that infliximab pretreatment signi-
ficantly attenuates ischemia-reperfusion injury via 
inhibiting TNF-a release. Further studies should 
investigate the underlying mechanism and evaluate 
the long-term safety, efficacy and the optimal dosage 
of infliximab as a protective agent in ischemia-reper-
fusion injury.
Table 2. Serum activities of transaminases and glutathione peroxidase and concentrations of TNF-a and malondialdehyde
Sham Pringle Infliximab + pringle
ALT (U/L) 38.5 ± 6.5* 2270.6 ± 313.9 278.9 ± 88.5†
AST (U/L) 72.7 ± 14.8* 498.1 ± 73.0 152.2 ± 18.5†
MDA (μmol/dL) 1.3 ± 0.1 1.7 ± 0.1* 1.3 ± 0.1
TNF-a (pg/mL) 32.2 ± 5.9 120.4 ± 36.7* 46.8 ± 9.8
GSH-Px (nmol/min/mL) 97.2 ± 39.7 37.7 ± 13.5* 74.5 ± 14.5
*p < 0.015 vs. other groups; † p < 0.015 vs. Pringle group. Data are presented as mean ± SD. ALT — alanine aminotransferase, AST — aspartate 
aminotransferase, MDA — malondialdehyde, TNF- a — tumor necrosis factor alpha, GSH-Px — glutathione peroxidase
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